The National Institutes of Health (NIH), specifically the National Institute on Drug Abuse (NIDA), is seeking proposals for a Proteomics Service to enhance the understanding of biological mechanisms related to alcohol and drug dependence. The procurement aims to secure a firm-fixed-price purchase order for the NULISAseq Mouse Panel 120 Service, which includes a minimum of 120 proteins targeting critical pathways in inflammation, neurodegeneration, and oncogenesis. This service is vital for advancing research that could lead to improved therapies for substance dependence, utilizing both specialized animal models and clinical trial samples. Interested offerors must submit their technical and price quotes by September 3, 2025, and all inquiries should be directed to Shaun Rostad at shaun.rostad@nih.gov by August 29, 2025.